Products
Our products
Learn more about the vaccines, specialty and general medicines that we market in India.
Our product areas
Our portfolio spans three product areas: vaccines, specialty and general medicines. Globally, we’re prioritising R&D investment in vaccines and specialty medicines, which we expect to grow to around three quarters of our business by 2026.
Business portfolio
Our company's product portfolio comprises a broad range of General Medicines which includes anti-infectives, pain management, vitamins minerals nutritionals, hormones, dermatologicals, respiratory and Vaccines for adults and children.Anti-Infectives
82 Mn
Patients were positively impacted through our anti-infectives portfolio.
Pain Management
104 Mn
Patients relied on Calpol as their preferred choice for managing fever and pain.
Respiratory
60,000
Patients suffering from asthma and COPD positively impacted through our respiratory portfolio.
Dermatologicals
20.3 Mn
Patients treated for their skin conditions through our extensive range of dermatological products
Vitamins Minerals Nutritionals
10.4 Mn
Patients touched annually with our vitamin and calcium range.
Hormones
8.6 Mn
Patients have been supported in their hypothyroidism treatment through Eltroxin.
Vaccines
3.5 Mn
Adults and children vaccinated for Vaccine Preventable Diseases.
Our focus brands across general medicines, vaccines and specialty products
General medicines
Vaccines
Specialty medicines
Our Specialty medicines in India
*Source: IQVIA MAT March 2023
Prescribing information
Detailed information about our medicines and vaccines for registered medical practitioners and regulators